These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8100580)

  • 1. A retrospective study of the effects of edentulism on the severity rating of tardive dyskinesia.
    Myers DE; Schooler NR; Zullo TG; Levin H
    J Prosthet Dent; 1993 Jun; 69(6):578-81. PubMed ID: 8100580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental prosthetic rehabilitation approach in tardive dyskinesia with edentulism: a case report.
    Blanchet PJ; Girard P; Gauthier G; Pampoulova T; Rompré PH; de Grandmont P
    Schizophr Res; 2012 Apr; 136(1-3):162-3. PubMed ID: 21798717
    [No Abstract]   [Full Text] [Related]  

  • 3. Subjective awareness of abnormal involuntary movements in schizophrenia.
    Sandyk R; Kay SR; Awerbuch GI
    Int J Neurosci; 1993; 69(1-4):1-20. PubMed ID: 7916006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year outcome of tardive dyskinesia.
    Gardos G; Casey DE; Cole JO; Perenyi A; Kocsis E; Arato M; Samson JA; Conley C
    Am J Psychiatry; 1994 Jun; 151(6):836-41. PubMed ID: 7910437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two iatrogenic dyskinesias.
    Karson CN; Jeste DV; LeWitt PA; Wyatt RJ
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of tardive dyskinesia. A multivariate analysis.
    Glazer WM; Morgenstern H; Niedzwiecki D; Hughes J
    Br J Psychiatry; 1988 Feb; 152():253-9. PubMed ID: 3262396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not all that moves is tardive dyskinesia.
    Khot V; Wyatt RJ
    Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia.
    Caligiuri MP; Harris MJ; Jeste DV
    Biol Psychiatry; 1988 Nov; 24(7):787-800. PubMed ID: 2906545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life.
    Sweet RA; Mulsant BH; Gupta B; Rifai AH; Pasternak RE; McEachran A; Zubenko GS
    Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC; Root L; Marmion J; Molinari V; Adams GL
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of orodental status to the intensity of orofacial tardive dyskinesia: an interdisciplinary and video-based assessment.
    Girard P; Monette C; Normandeau L; Pampoulova T; Rompré PH; de Grandmont P; Blanchet PJ
    J Psychiatr Res; 2012 May; 46(5):684-7. PubMed ID: 22386652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.